1-20 of 23
hydroxyurea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management

Oyebimpe O. Adesina, Lynne D. Neumayr
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 351–358.
https://doi.org/10.1182/hematology.2019000038
Published: 2019
Journal Articles

Sickle cell disease: a comprehensive program of care from birth

Mariane de Montalembert, Léon Tshilolo, Slimane Allali
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 490–495.
https://doi.org/10.1182/hematology.2019000053
Published: 2019
Journal Articles

Optimizing hydroxyurea therapy for sickle cell anemia

Russell E. Ware
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 436–443.
https://doi.org/10.1182/asheducation-2015.1.436
Published: 2015
Journal Articles

Does hydroxyurea prevent pulmonary complications of sickle cell disease?

Tyler W. Buckner, Kenneth I. Ataga
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 432–437.
https://doi.org/10.1182/asheducation-2014.1.432
Published: 2014
Journal Articles

Therapy for myeloproliferative neoplasms: when, which agent, and how?

Holly L. Geyer, Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 277–286.
https://doi.org/10.1182/asheducation-2014.1.277
Published: 2014
Journal Articles

Treating acute myeloid leukemia in older adults

Eunice S. Wang
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 14–20.
https://doi.org/10.1182/asheducation-2014.1.14
Published: 2014
Journal Articles

Reproductive issues in sickle cell disease

Kim Smith-Whitley
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 418–424.
https://doi.org/10.1182/asheducation-2014.1.418
Published: 2014
Journal Articles

Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

Deepa Manwani, Paul S. Frenette
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 362–369.
https://doi.org/10.1182/asheducation-2013.1.362
Published: 2013
Journal Articles

What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease?

Deepika S. Darbari, Julie A. Panepinto
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 290–291.
https://doi.org/10.1182/asheducation.V2012.1.290.3798273
Published: 2012
Journal Articles

Secondary Prevention of Overt Strokes in Sickle Cell Disease: Therapeutic Strategies and Efficacy

Michael R. DeBaun
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 427–433.
https://doi.org/10.1182/asheducation-2011.1.427
Published: 2011
Journal Articles

Primary Prophylaxis in Sickle Cell Disease: Is It Feasible? Is It Effective?

Alexis A. Thompson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 434–439.
https://doi.org/10.1182/asheducation-2011.1.434
Published: 2011
Journal Articles

What Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?

Jeffrey D. Lebensburger, Michael R. DeBaun, Alexis A. Thompson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 440–442.
https://doi.org/10.1182/asheducation-2011.1.440
Published: 2011
Journal Articles

Management of Essential Thrombocythemia

Francisco Cervantes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 215–221.
https://doi.org/10.1182/asheducation-2011.1.215
Published: 2011
Journal Articles

Advances in the use of hydroxyurea

Russell E. Ware, Banu Aygun
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 62–69.
https://doi.org/10.1182/asheducation-2009.1.62
Published: 2009
Journal Articles

Hemoglobin E Syndromes

Elliott Vichinsky
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 79–83.
https://doi.org/10.1182/asheducation-2007.1.79
Published: 2007
Journal Articles

Limitations of Clinical Trials in Sickle Cell Disease: A Case Study of the Multi-center Study of Hydroxyurea (MSH) Trial and the Stroke Prevention (STOP) Trial

Michael R. DeBaun, Joshua J. Field
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 482–488.
https://doi.org/10.1182/asheducation-2007.1.482
Published: 2007
Journal Articles

Induction of Fetal Hemoglobin in the Treatment of Sickle Cell Disease

Hassana Fathallah, George F. Atweh
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 58–62.
https://doi.org/10.1182/asheducation-2006.1.58
Published: 2006
Journal Articles

An Evidence-Based Approach to the Treatment of Adults with Sickle Cell Disease

Richard Lottenberg, Kathryn L. Hassell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 58–65.
https://doi.org/10.1182/asheducation-2005.1.58
Published: 2005
Journal Articles

Management of Polycythemia Vera and Essential Thrombocythemia

Peter J. Campbell, Anthony R. Green
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 201–208.
https://doi.org/10.1182/asheducation-2005.1.201
Published: 2005
Journal Articles

Sickle Cell Disease

George R. Buchanan, Michael R. DeBaun, Charles T. Quinn, Martin H. Steinberg
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 35–47.
https://doi.org/10.1182/asheducation-2004.1.35
Published: 2004